HomeADVM • NASDAQ
add
Adverum Biotechnologies Inc
$2.47
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$2.47
Sarado: Hun 4, 4:01:48 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$2.51
Sakop ng araw
$2.43 - $2.54
Sakop ng taon
$1.78 - $10.14
Market cap
51.60M USD
Average na Volume
502.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 19.47M | 41.23% |
Net na kita | -47.02M | -73.20% |
Net profit margin | — | — |
Kita sa bawat share | -2.25 | -50.00% |
EBITDA | -47.54M | -68.56% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 83.08M | -57.02% |
Kabuuang asset | 137.65M | -48.60% |
Kabuuang sagutin | 111.23M | 30.04% |
Kabuuang equity | 26.42M | — |
Natitirang share | 20.89M | — |
Presyo para makapag-book | 1.99 | — |
Return on assets | -75.94% | — |
Return on capital | -85.49% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -47.02M | -73.20% |
Cash mula sa mga operasyon | -42.77M | -84.00% |
Cash mula sa pag-invest | 31.28M | 242.01% |
Cash mula sa financing | — | — |
Net change in cash | -11.49M | -115.40% |
Malayang cash flow | -27.04M | -67.12% |
Tungkol
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Itinatag
Ene 1, 2006
Headquarters
Website
Mga Empleyado
155
